Skip to main content

Breadcrumb

  1. Home

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

Submitted by korinna@manifo… on Fri, 01/16/2026 - 19:46
  • Read more about FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Submitted by korinna@manifo… on Fri, 01/16/2026 - 19:46
  • Read more about A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

Submitted by korinna@manifo… on Fri, 01/16/2026 - 19:44
  • Read more about A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

Submitted by korinna@manifo… on Tue, 01/06/2026 - 13:52
  • Read more about Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

Supporting Responsible Fatherhood Program (Fatherhood FIRE)

Submitted by korinna@manifo… on Tue, 01/06/2026 - 13:51
  • Read more about Supporting Responsible Fatherhood Program (Fatherhood FIRE)

A Study of CTD402 in T-ALL/LBL Patients

Submitted by korinna@manifo… on Wed, 12/31/2025 - 20:12
  • Read more about A Study of CTD402 in T-ALL/LBL Patients

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Submitted by korinna@manifo… on Mon, 12/29/2025 - 14:41
  • Read more about TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Submitted by korinna@manifo… on Mon, 12/29/2025 - 14:41
  • Read more about ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lu

Submitted by korinna@manifo… on Mon, 12/29/2025 - 14:41
  • Read more about A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lu

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Submitted by korinna@manifo… on Mon, 12/29/2025 - 14:41
  • Read more about Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page Next
  • Last page Last
Subscribe to